Presentation ACC 2025 Two-year Outcomes Of Transcatheter Tricuspid Valve Edge-to-Edge Repair For Tricuspid Regurgitation: The TRILUMINATE Pivotal Trial Presenter: Saibal Kar March 30, 2025 REGISTER for free or LOG IN to view this content Structural Heart Tricuspid Valve Presentation ACC 2025 Up Next Presentation ACC 2025 Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial Presenter: Joo-Yong Hahn March 29, 2025 More slides + Presentation ACC 2025 FAIR-HF2 Trial: Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality Presenter: Stefan D. Anker March 30, 2025 Presentation ACC 2025 Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial Presenter: William Fearon March 30, 2025 We Recommend
Presentation ACC 2025 Clopidogrel versus Aspirin Monotherapy in Patients with High Ischemic Risk after PCI: SMART-CHOICE 3 Trial Presenter: Joo-Yong Hahn March 29, 2025
Presentation ACC 2025 FAIR-HF2 Trial: Intravenous iron in patients with systolic heart failure and iron deficiency to improve morbidity & mortality Presenter: Stefan D. Anker March 30, 2025
Presentation ACC 2025 Outcomes after FFR-Guided PCI vs. CABG: Final 5-Year Follow-up of the FAME 3 Trial Presenter: William Fearon March 30, 2025